Get the Stockscreener App
6.84
2.55%
0.17
After Hours:
7.10
0.26
+3.80%
Pepgen Inc stock is traded at $6.84, with a volume of 492.77K.
It is up +2.55% in the last 24 hours and up +25.74% over the past month.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
See More
Previous Close:
$6.67
Open:
$6.67
24h Volume:
492.77K
Relative Volume:
0.62
Market Cap:
$470.24M
Revenue:
-
Net Income/Loss:
$-87.23M
P/E Ratio:
-2.303
EPS:
-2.97
Net Cash Flow:
$-82.77M
1W Performance:
+6.54%
1M Performance:
+25.74%
6M Performance:
+460.66%
1Y Performance:
+85.87%
1-Day Range:
$6.52
$6.90
1-Week Range:
$6.28
$7.80
52-Week Range:
$0.8801
$7.80
Pepgen Inc Stock (PEPG) Company Profile
Name
Pepgen Inc
Sector
Industry
Phone
703-456-8000
Address
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Compare PEPG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
6.84 | 458.55M | 0 | -87.23M | -82.77M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-09-25 | Initiated | Guggenheim | Buy |
| Dec-16-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-21-22 | Initiated | H.C. Wainwright | Buy |
Pepgen Inc Stock (PEPG) Latest News
Will PepGen Inc. stock return to pre crisis levels2026 world cup usa national team qualification top scorers high defensive line odds analysis analysis - Улправда
Will PepGen Inc. stock gain from lower inflation2026 world cup usa national team semifinals top scorers high defensive line winner prediction expert opinion - Улправда
Is PepGen Inc. stock supported by innovation pipeline2026 world cup usa national team qualification key players possession football knockout prediction analysis - Улправда
What analysts say about PepGen Inc stockRelative Strength Index (RSI) & Double Digit Profit Strategies - earlytimes.in
Update Recap: Is PepGen Inc stock supported by strong fundamentalsJuly 2025 Decliners & Weekly High Return Forecasts - moha.gov.vn
Downgrade Watch: How YSG stock behaves in tightening cyclesJuly 2025 Market Mood & Expert Verified Stock Movement Alerts - moha.gov.vn
PepGen, Inc. (NASDAQ:PEPG) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
PepGen, Inc. (NASDAQ:PEPG) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
PepGen (NASDAQ:PEPG) Reaches New 12-Month HighWhat's Next? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PepGen Inc. (PEPG) And Encourages Shareholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PepGen Inc. (PEPG) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Insider Trends: Can PepGen Inc stock beat market expectations this quarterWeekly Trade Analysis & Reliable Price Breakout Alerts - moha.gov.vn
PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
PepGen Inc. (PEPG) AI-Powered Stock Analysis - Meyka
Bronstein, Gewirtz & Grossman, LLC Is Investigating PepGen Inc. (PEPG) And Encourages Investors to Connect - ACCESS Newswire
PepGen Buy Rating: De-Risked Safety and Potential Category-Leading Efficacy for PGN-EDODM1 in DM1 Ahead of 1Q26 MAD Readout - TipRanks
Is PepGen Inc. stock a top pick in earnings seasonJuly 2025 Patterns & Expert Approved Momentum Ideas - Улправда
Why PepGen Inc. stock appeals to dividend seekersJuly 2025 Intraday Action & Expert Curated Trade Setup Alerts - Улправда
Traders Buy High Volume of PepGen Call Options (NASDAQ:PEPG) - Defense World
PepGen Sees Unusually High Options Volume (NASDAQ:PEPG) - MarketBeat
VIX Spike: Will PepGen Inc. stock gain from lower inflationWeekly Trend Report & AI Based Buy/Sell Signal Reports - Улправда
Can PepGen Inc. stock deliver consistent earnings growth2025 Support & Resistance & Safe Capital Investment Plans - DonanımHaber
Can PepGen Inc. stock beat market expectations this quarterInflation Watch & Safe Capital Growth Stock Tips - DonanımHaber
Geopolitics Watch: Is PepGen Inc. stock a top pick in earnings season2025 Trading Volume Trends & Technical Entry and Exit Tips - Улправда
PepGen (PEPG) cuts executive stock option strike from $9.83 to $4.53 - Stock Titan
[Form 4] PepGen Inc. Insider Trading Activity - Stock Titan
PepGen (PEPG) cuts CFO stock option strike prices to $4.53 - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PepGen Inc. (PEPG) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
US Market Wrap: Why PepGen Inc. stock appeals to dividend seekersWeekly Profit Analysis & Accurate Buy Signal Notifications - Улправда
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PepGen Inc. (PEPG) And Encourages Stockholders to Reach Out - ACCESS Newswire
PepGen appoints Joseph Vittiglio as chief business, legal officer - MSN
Movement Recap: How buybacks impact PepGen Inc stock valueQuarterly Growth Report & Daily Profit Maximizing Trade Tips - moha.gov.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating PepGen Inc. (PEPG) And Encourages Stockholders to Connect - ACCESS Newswire
How much upside is left in PepGen (PEPG)? Wall Street analysts think 75.44% - MSN
How Much Upside is Left in PepGen (PEPG)? Wall Street Analysts Think 75.44% - Zacks Investment Research
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer - BioSpace
PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer - BioSpace
Quant Funds Rotate Into Lead Reclaim and Rubber Products Limited StockSwing Trading Ideas & Superior Wealth Growth - earlytimes.in
PepGen, Inc. (NASDAQ:PEPG) Given Average Recommendation of "Hold" by Analysts - MarketBeat
PepGen (NASDAQ:PEPG) Targets Next-Gen Treatment Pathways In Biotech - Kalkine Media
PepGen appoints Joseph Vittiglio as chief business and legal officer - Investing.com
PepGen appoints Joseph Vittiglio, Esq., as chief business and legal officer - marketscreener.com
PepGen Inc. Appoints New Chief Business Officer - TipRanks
PepGen appoints Joseph Vittiglio as chief business and legal officer By Investing.com - Investing.com Canada
PepGen Inc Appoints New Chief Business and Legal Officer - TradingView — Track All Markets
Pepgen Inc. Appoints Joseph Vittiglio as Chief Business and Legal Officer, Effective December 8, 2025 - marketscreener.com
Pepgen Inc Stock (PEPG) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):